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Malaria is spread by the bite of a female Anopheles mosquito. 
The disease can cause fever, chills, and flu-like illness. If it is not 
treated, it may cause severe complications and death.
CDC and Malaria
The Centers for Disease Control and Prevention (CDC) played 
a critical role in eliminating malaria from the United States 
by 1951. Now CDC provides scientific leadership in fighting 
malaria at home and around the globe.
CDC At Work Around the World 
CDC scientists provide expertise to develop evidence-based 
policies and programs, critical scientific innovations to 
help guide the agenda for future public health efforts, and 
monitoring and evaluation of progress toward global malaria 
goals. These activities are conducted in malaria-endemic 
countries with Ministry of Health colleagues, both to inform 
local policy and to share the information developed with the 
global malaria community. 
CDC is a member of the Roll Back Malaria partnership, which 
consists of more than 500 partners, including malaria-endemic 
countries, bilateral and multilateral development partners, 
private sector, nongovernmental and community-based 
organizations, foundations, and research and academic 
institutions. This strong global alliance is making strong 
progress in reducing the health burden of malaria.
CDC also works to keep malaria from resurging in the U.S. 
by monitoring imported cases, responding to infrequent 
outbreaks in the United States, and providing guidance to 
protect U.S. travelers.
Malaria’s Burden
The World Health Organization estimates that malaria 
caused approximately 660,000 deaths in 2010—mostly 
young children in sub-Saharan Africa. In Africa alone, costs 
of illness, treatment, and premature death from malaria are 
at least $12 billion per year.
Malaria’s toll would be much higher without the efforts 
of CDC and other global partners. In the last decade, with 
large increases in funding to support scale-up of malaria 
prevention and treatment interventions, approximately 1.1 
million lives have been saved, and malaria cases and deaths 
have sharply decreased—by 25% globally and by 33% in 
sub-Saharan Africa. However, malaria remains a major public 
health problem that is preventable and treatable.
U.S.Government Health Initiatives
CDC’s Mandate. CDC is specifically directed by the U.S. Congress through 2008’s Lantos-Hyde Act to provide leadership in 
the areas of monitoring, evaluation, surveillance, and operational research for malaria. We work to track malaria transmission 
so that public health officials can treat cases and prevent new ones, to understand a changing malaria situation and adapt 
interventions accordingly, and to measure our progress towards achieving our goals of control, elimination, and ultimately 
eradication.
President’s Malaria Initiative. CDC implements the U.S. President’s Malaria Initiative (PMI) jointly with the U.S. Agency for 
International Development (USAID). PMI and its global partners have massively scaled up effective malaria interventions, and 
PMI’s goal of halving the malaria burden in 70% of at-risk populations in sub-Saharan Africa by 2014 has been achieved in 
one of its 19 target countries and is very close in several others. PMI also monitors antimalarial drug resistance in the Greater 
Mekong subregion of Southeast Asia and works to prevent and control the spread of multidrug-resistant malaria so that 
successes achieved in global malaria efforts are not reversed.
Amazon Malaria Initiative (AMI). CDC provides technical expertise in monitoring of antimalarial drug resistance, molecular 
biology, and entomology to countries in Central and South America. By working with other partners, such as USAID, CDC 
helps strengthen data-based decision making in malaria control programs in the region
Conducting Strategic Research
CDC provides scientific leadership in public health efforts to 
fight malaria. 
 • CDC’s science has increased global understanding and 
capacity to prevent death and illness from malaria, 
especially among those most vulnerable to the disease—
pregnant women and children. 
 • Our science has contributed to defining the impact 
of antimalarial drug resistance—a threat to current 
malaria successes— and ways to prevent its spread. In 
collaboration with the World Health Organization, CDC 
has established evidence-based guidelines used by 
national malaria control programs worldwide. 
 • CDC has helped develop and evaluate all four of the key 
prevention and control interventions recommended by 
WHO and used by programs worldwide to fight malaria
 » Insecticide-treated bed nets (ITNs) to protect people 
from mosquitoes
 » Rapid diagnostic tests and treatment with effective 
high-quality drugs: artemisinin-containing 
combination therapies (ACTs)
 » Treatment to protect pregnant women and their 
newborn children: intermittent preventive treatment 
(IPTp) for pregnant women
 » Indoor spraying of homes to protect people from 
mosquitoes (IRS)
 • CDC is currently conducting research to refine the 
use of these proven interventions to maximize their 
effectiveness and overcome challenges. 
 • The agency also conducts cutting-edge research and 
development in the laboratory and field on transmission 
of the malaria parasite, drug resistance, and human 
immunological and pathologic responses to malaria. 
Having informed the current generation of malaria control 
interventions through its strong science and research, CDC is 
working to refine malaria interventions and develop new tools 
to stay ahead of the curve and ensure continued success of 
global investments. 
CDC provided technical expertise to a President’s Malaria Initiative study in Tanzania 
designed to determine how best to introduce malaria rapid diagnostic tests to 
improve diagnostic capability and prescribing practices.
Protecting Individuals at Home in the  
United States
CDC protects people living in the U.S. from the threat posed 
by reintroduction of malaria from the approximately 1,500 
travelers per year who develop malaria abroad and then arrive 
in or return to the U.S. As the nation’s public health agency, 
CDC tracks rates of reported malaria cases to detect increases 
of concern, provides guidance to U.S. international travelers 
to prevent them from becoming infected abroad, and advises 
physicians on the accurate diagnosis and treatment of malaria 
in the U.S. 
For more information, see www.cdc.gov/malaria or email  
malaria@cdc.gov
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